Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Blueprint Medicines Corp
(NQ:
BPMC
)
92.26
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
92.26
Bid (Size)
65.00 (1)
Ask (Size)
105.00 (1)
Prev. Close
92.26
Today's Range
92.26 - 92.26
52wk Range
43.89 - 101.00
Shares Outstanding
61,232,297
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Decoding 6 Analyst Evaluations For Blueprint Medicines
April 10, 2024
Via
Benzinga
(BPMC) - Analyzing Blueprint Medicines's Short Interest
February 20, 2024
Via
Benzinga
Performance
YTD
+1.31%
+1.31%
1 Month
+4.58%
+4.58%
3 Month
+12.68%
+12.68%
6 Month
+109.87%
+109.87%
1 Year
+88.86%
+88.86%
More News
Read More
Blueprint Medicines Corp. (NASDAQ: BPMC) Climbs to New 52-Week High
February 16, 2024
Via
Investor Brand Network
Reliance Steel & Aluminum Posts Upbeat Earnings, Joins JFrog, AppLovin, Shake Shack And Other Big Stocks Moving Higher On Thursday
February 15, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Earnings Scheduled For February 15, 2024
February 15, 2024
Via
Benzinga
Blueprint Medicines's Earnings Outlook
February 14, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Blueprint Medicines
February 13, 2024
Via
Benzinga
Peeling Back The Layers: Exploring Blueprint Medicines Through Analyst Insights
January 09, 2024
Via
Benzinga
Blueprint Medicines Outranks 92% Of All Stocks. But This Could Be Its Undoing.
February 15, 2024
Via
Investor's Business Daily
Raymond James Maintains Strong Buy Rating for Blueprint Medicines: Here's What You Need To Know
December 22, 2023
Via
Benzinga
Chart Of The Day: Does Blueprint Medicines Have A Blueprint For Success?
December 13, 2023
Via
Talk Markets
Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session
December 11, 2023
Via
Benzinga
The Latest Analyst Ratings for Blueprint Medicines
December 11, 2023
Via
Benzinga
Needham Maintains Buy Rating for Blueprint Medicines: Here's What You Need To Know
October 27, 2023
Via
Benzinga
Barclays Maintains Equal-Weight Rating for Blueprint Medicines: Here's What You Need To Know
October 27, 2023
Via
Benzinga
Why Blueprint Medicines Stock Soared Today
October 26, 2023
Via
The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
October 26, 2023
Via
Benzinga
Blueprint Medicines Corp. (NASDAQ: BPMC) Leading the Way in Thursday Trading Based on Percentage Gain
October 26, 2023
Via
Investor Brand Network
Blueprint Medicines's Earnings: A Preview
October 25, 2023
Via
Benzinga
Unpacking Blueprint Medicines' Ayvakit's Bright Future: Insights From Latest Physician Survey On Sales Predictions
August 21, 2023
Via
Benzinga
Analyst Ratings for Blueprint Medicines
August 21, 2023
Via
Benzinga
What 15 Analyst Ratings Have To Say About Blueprint Medicines
August 02, 2023
Via
Benzinga
Why Shares of Blueprint Medicines Are Falling Wednesday
August 02, 2023
Via
The Motley Fool
Why Harley-Davidson Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
October 26, 2023
Via
Benzinga
IBM, ServiceNow, Lennox, Morningstar And Other Big Stocks Moving Higher On Thursday
October 26, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.